Pie Medical Imaging

Executive Summary

Pie Medical Imaging (PMI) is a Netherlands-based medical device software company founded in 1995, specializing in quantitative analysis and guidance for cardiovascular imaging. Its product suite supports percutaneous coronary intervention, structural heart procedures, cardiac diagnostics, and vascular surgery. As a private, established player in the cardiac imaging software market, PMI benefits from strong brand recognition among interventional cardiologists and a long track record of FDA-cleared and CE-marked products. However, limited public information on recent funding or partnerships suggests a mature, self-sustaining business with moderate growth prospects. The company faces competition from larger players like GE Healthcare, Philips, and Canon, but retains a niche in dedicated quantitative coronary angiography (QCA) and 3D modeling software. Future growth may hinge on expanding into new geographies, integrating AI-driven analytics, or deepening its presence in structural heart planning.

Upcoming Catalysts (preview)

• Q4 2026New AI-powered software module for automated coronary analysis70% success
• Q2 2027Strategic partnership with a major European hospital network for workflow integration50% success
• Q3 2026FDA clearance for next-generation structural heart planning software80% success